Herantis Pharma

Develops experimental therapies for people with Parkinson’s disease

Espoo, FinlandFounded 2008herantis.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Herantis Pharma

Herantis Pharma is a clinical-stage biotechnology company developing neurorestorative therapies intended to slow or stop the progression of Parkinson’s disease. Its lead candidate, HER-096, is a CDNF-derived peptidomimetic that has completed Phase 1 clinical development and is being prepared for a Phase 2 proof-of-concept trial.

The company targets the global Parkinson’s disease market and seeks partnerships for late-stage clinical development and commercialization.

Founded in 2008 and headquartered in Espoo, Finland, Herantis Pharma is listed on Nasdaq First North Growth Market Finland under the ticker HRTIS.

Product: HER-096 is an experimental CDNF-derived peptidomimetic being developed as a potential disease-modifying therapy for Parkinson’s disease.

Jobs at Herantis Pharma

No open positions listed right now.

Leadership

More biotech & pharma companies

  • HumGel

    Human tumor-derived cell matrix (MyoGel) for cancer research labs running invasion and drug-testing assays
    Oulu, FinlandBiotech & pharmaFounded 2026
    Young companyNew on Evolc
  • KÄÄPÄ BioTech

    Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developers
    Karjalohja, FinlandBiotech & pharmaFounded 2018
    New on Evolc
  • LignoSphere Company

    Colloidal lignin particles from kraft lignin for coating and adhesive manufacturers seeking fossil-free phenolic substitutes
    Espoo, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc
  • Linio Biotech

    Regenerative tissue platform (Tience) for skin and soft-tissue defect treatment, used by clinicians in the Nordics
    Helsinki, FinlandBiotech & pharmaFounded 2017
    New on Evolc
  • Medicortex Finland

    Develops biomarker-based diagnostic tests for traumatic brain injury and concussion
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc
  • Misvik Biology

    Cancer drug screening and preclinical research services for biopharma companies and academic institutions
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Bootstrap
  • WordPress
  • jQuery
  • nginx